Thousands of plaintiffs who opted out of the settlement in the massive fen-phen diet drug litigation lost a pair of significant appeals Monday that demanded their cases be sent back to courts in their home states for possible trial.

But the decisions handed down Monday by the 3rd U.S. Circuit Court of Appeals may prove to be moot, as court records show that several groups of plaintiffs lawyers are in the final stages of negotiating a settlement of nearly all the remaining cases.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]